Microglial function modulators (Janssen Pharmaceuticals)

N/A

Report date: 2025/01/26 15:49:53
NME

Base Information

Drug NameMicroglial function modulators (Janssen Pharmaceuticals)
Drug Alias NameMicroglial function modulators (St Vincent's Institute/Janssen Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta amyloid A4 protein inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSt Vincent's Institute Medical Research
China Registration ClassN/A

Develop Information

Active CompaniesJanssen Pharmaceuticals Inc
Inactive CompaniesSt Vincent's Institute Medical Research
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A